ReviewAdvances in experimental medicine and biology2026
Immunomodulatory Effects of Medicinal Plants.
Review in Advances in experimental medicine and biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Medicinal plants have long been recognized for their therapeutic benefits, particularly for their bioactive compounds that enhance quality of life. These plants and their derived compounds possess numerous pharmacological properties, including the modulation of immune system components. Immune responses are crucial for resolving oral infections caused by pathogens such as bacteria, fungi, and viruses, as well as for preventing or managing oral cancer. A robust immune system plays a central role in defending against these stimuli, making it essential to explore and promote the use of medicinal plants that can enhance immune responses or intervene in disease-related processes.This chapter focuses on the immunomodulatory potential of specific plants and plant-derived compounds, specifying their bioactive chemical components responsible for their immune-boosting and anti-inflammatory properties. Many medicinal plants exhibit considerable immunomodulatory activities, primarily through the activation of signaling pathways like NF-κB and MAPK. These pathways are key regulators of inflammatory diseases and cancer, and their modulation by plant compounds holds promise for therapeutic applications. However, further studies are required to fully elucidate the underlying mechanisms of these effects and to explore additional pathways involved in plant-based immunomodulation.Most studies on the immunomodulatory effects of medicinal plants have been conducted in vitro, so it is crucial to expand research into randomized clinical trials in diverse populations. Although many of the plants discussed in this chapter appear to be safe, their toxicological profiles in clinical settings remain underexplored and need further investigation. By advancing clinical research and assessing the safety and efficacy of medicinal plants, these natural products could play an increasingly important role in managing oral infections, cancer, and other immune-related conditions.
Indexed as
Identifiers
41225123What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.